A novel tricyclic thiazepine derivative, 6-(p-tolyl)benzo[f] pyrido[2,3-b][1,4] thiazepine 11,11-dioxide (TBPT), exhibits potent inhibitory effects in two non-small-cell lung cancer cell lines, H460 and its drug-resistant variant, H460
TaxR, while exhibiting much less toxic effects on normal human fibroblasts. After five injections of TBPT at a dose of 60 mg/kg, it inhibits H460
TaxR tumor growth in xenografted mouse models by 66.7% without causing observable toxicity to normal tissues. Based on gene perturbation data and a series of investigations, we reveal that TBPT is not a P-glycoprotein substrate and it inhibits microtubule formation by targeting tubulin, thereby causing cell cycle arrest at the G2/M stage and eventually inducing apoptosis. This redeployment of anti-depressant compound scaffold for anticancer applications provides a promising future for conquering drug-resistant tumors with fewer side effects.Drug resistance and nonselective toxicity have been two major clinical obstacles for cancer chemotherapy.
1, 2, 3, 4, 5 Drug resistance is responsible for treatment failure in >90% of patients with metastatic cancers.
6 A major cause of drug resistance is the overexpression of a 170-kDa transmembrane protein, P-glycoprotein (P-gp), on the cancer cell surface in response to drug treatment. P-gp acts as an ATP-dependent drug efflux pump.
7, 8, 9 Many drugs, including paclitaxel (PTX), taxanes, doxorubicin and vinca alkaloids are substrates of P-gp and are readily pumped out of cells, thereby leading to reduced drug accumulation inside cells.
1, 10 Furthermore, anticancer drugs often elicit serious nonselective toxicity to normal organs. Patients who have undergone chemotherapy often suffer from treatment-related morbidity or mortality, such as leukopenia, hepatic toxicity and even death.
11, 12, 13, 14 Therefore, potent and selective agents against multidrug-resistant cancers are urgently needed.Tricyclic azepine derivatives, such as tianeptine, clomipramine and quetiapine, have been used as anti-psychotic drugs. Other reports have demonstrated that tricyclic azepine derivatives such as nevirapine work as anti-human immunodeficiency virus agents.
15, 16 A recent report has also demonstrated that tricyclic anti-depressants such as clomipramine exhibit anticancer activity.
17 In this work, we report the good activity and superb selectivity of a tricyclic thiazepine compound, 6-(p-tolyl)benzo[f] pyrido[2,3-b][1,4] thiazepine 11,11-dioxide (TBPT) against drug-resistant non-small-cell lung cancer (NSCLC). TBPT inhibited the growth of both drug-sensitive and drug-resistant human lung cancer cells
in vitro and drug-resistant tumors
in vivo without obvious side effects. Further examination indicated that TBPT evaded the P-gp-mediated drug efflux and acted as a novel microtubule depolymerizing agent, thereby inducing cancer cell G2/M phase arrest and apoptosis.
相似文献